{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:40:42Z","timestamp":1791423642951,"version":"4.3.3"},"reference-count":107,"publisher":"The Endocrine Society","issue":"Supplement_1","license":[{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Swedish government","award":["ALFGBG-983782"],"award-info":[{"award-number":["ALFGBG-983782"]}]},{"name":"Swedish government","award":["ALFGBG-966066"],"award-info":[{"award-number":["ALFGBG-966066"]}]},{"DOI":"10.13039\/501100002794","name":"Swedish Cancer Society","doi-asserted-by":"publisher","award":["211774 Pj"],"award-info":[{"award-number":["211774 Pj"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Crinetics Pharmaceuticals, Inc"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Epidemiologic research for rare diseases such as acromegaly is challenging due to low prevalence, heterogeneous data sources, and regional variability. Here, we review recent epidemiologic studies and provide a synthesis of the changing landscape of acromegaly and an overview of mortality rates and their determinants.<\/jats:p>\n                  <jats:p>Over the past few decades, the reported incidence and prevalence of acromegaly have increased, likely due to improved diagnostic tools, earlier diagnosis, and more efficient management of the disease, leading to increased life expectancy. Available data suggest that the delay in diagnosis of acromegaly has progressively declined, and there is now a considerable increase in the rate of biochemical control\u2014achieved in up to 90% of patients in some centers. This progress reflects improvements in disease management with the expanding use of multimodal and personalized treatment strategies. Consequently, mortality rates have substantially declined, approaching those of the general population. Despite these advances, most patients continue to be diagnosed only after acromegaly complications have developed. Comorbidities still have an independent and adverse effect on mortality and morbidity. Therefore, improved management of comorbidities is the optimal goal in the overall treatment of patients with acromegaly.<\/jats:p>","DOI":"10.1210\/clinem\/dgag150","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T11:42:23Z","timestamp":1775216543000},"page":"S1-S12","source":"Crossref","is-referenced-by-count":2,"title":["Changing understanding of acromegaly epidemiology and early mortality risk"],"prefix":"10.1210","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8993-2071","authenticated-orcid":false,"given":"Daniela","family":"Esposito","sequence":"first","affiliation":[{"name":"Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg , Gothenburg 40530 ,","place":["Sweden"]},{"name":"Department of Endocrinology, Sahlgrenska University Hospital , Gothenburg 413 45 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3484-8440","authenticated-orcid":false,"given":"Gudmundur","family":"Johannsson","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg , Gothenburg 40530 ,","place":["Sweden"]},{"name":"Department of Endocrinology, Sahlgrenska University Hospital , Gothenburg 413 45 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2026,4,8]]},"reference":[{"issue":"11","key":"2026060416132333900_dgag150-B1","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S2213-8587(22)00244-3","article-title":"Acromegaly: pathogenesis, diagnosis, and management","volume":"10","author":"Fleseriu","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"24","key":"2026060416132333900_dgag150-B2","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1056\/NEJMra062453","article-title":"Medical progress: acromegaly","volume":"355","author":"Melmed","year":"2006","journal-title":"N Engl J Med"},{"issue":"1","key":"2026060416132333900_dgag150-B3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11102-020-01091-7","article-title":"A Pituitary Society update to acromegaly management guidelines","volume":"24","author":"Fleseriu","year":"2021","journal-title":"Pituitary"},{"issue":"6","key":"2026060416132333900_dgag150-B4","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1530\/EJE-20-0019","article-title":"Prolonged diagnostic delay in acromegaly is associated with increased morbidity and mortality","volume":"182","author":"Esposito","year":"2020","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2026060416132333900_dgag150-B5","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1530\/EJE-18-0255","article-title":"Mortality in acromegaly decreased in the last decade: a systematic review and meta-analysis","volume":"179","author":"Bolfi","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2026060416132333900_dgag150-B6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1023\/A:1009965803750","article-title":"Epidemiology of acromegaly","volume":"2","author":"Holdaway","year":"1999","journal-title":"Pituitary"},{"issue":"3","key":"2026060416132333900_dgag150-B7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF03344942","article-title":"Acromegaly: an epidemiological study","volume":"16","author":"Etxabe","year":"1993","journal-title":"J Endocrinol Invest"},{"issue":"10","key":"2026060416132333900_dgag150-B8","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1507\/endocrj.EJ20-0129","article-title":"Prevalence, incidence, comorbidities, and treatment patterns among Japanese patients with acromegaly: a descriptive study using a nationwide claims database","volume":"67","author":"Matsubayashi","year":"2020","journal-title":"Endocr J"},{"issue":"3","key":"2026060416132333900_dgag150-B9","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s11102-015-0701-2","article-title":"Incidence and prevalence of acromegaly in a large US health plan database","volume":"19","author":"Burton","year":"2016","journal-title":"Pituitary"},{"issue":"3","key":"2026060416132333900_dgag150-B10","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s12020-018-1630-4","article-title":"Epidemiology of acromegaly in Italy: analysis from a large longitudinal primary care database","volume":"61","author":"Gatto","year":"2018","journal-title":"Endocrine"},{"issue":"1","key":"2026060416132333900_dgag150-B11","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11102-016-0754-x","article-title":"Epidemiology of acromegaly: review of population studies","volume":"20","author":"Lavrentaki","year":"2017","journal-title":"Pituitary"},{"issue":"6","key":"2026060416132333900_dgag150-B12","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s11102-015-0655-4","article-title":"The incidence and prevalence of acromegaly, a nationwide study from 1955 through 2013","volume":"18","author":"Hoskuldsdottir","year":"2015","journal-title":"Pituitary"},{"issue":"6","key":"2026060416132333900_dgag150-B13","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/cen.14828","article-title":"The prevalence of acromegaly is higher than previously reported: changes over a three-decade period","volume":"97","author":"Aagaard","year":"2022","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2026060416132333900_dgag150-B14","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/cen.15264","article-title":"High-density lipoprotein cholesterol levels and the risk of acromegaly: a nationwide cohort study","volume":"103","author":"Roh","year":"2025","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"2026060416132333900_dgag150-B15","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ando.2024.09.002","article-title":"Acromegaly: incidence, patient characteristics and treatment patterns in a 10-year nationwide retrospective hospital cohort study","volume":"85","author":"Fauchier","year":"2024","journal-title":"Ann Endocrinol (Paris)"},{"issue":"4","key":"2026060416132333900_dgag150-B16","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s40618-023-02217-x","article-title":"Establishing a valid cohort of patients with acromegaly by combining the National Patient Register with the Swedish Pituitary Register","volume":"47","author":"Rob\u00e8rt","year":"2024","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"2026060416132333900_dgag150-B17","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s11154-024-09875-z","article-title":"The changing landscape of acromegaly \u2013 an epidemiological perspective","volume":"25","author":"Rosendal","year":"2024","journal-title":"Rev Endocr Metab Disord"},{"issue":"1","key":"2026060416132333900_dgag150-B18","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s12020-022-03275-6","article-title":"Trends in incidence and mortality risk for acromegaly in Norway: a cohort study","volume":"80","author":"Falch","year":"2023","journal-title":"Endocrine"},{"issue":"3","key":"2026060416132333900_dgag150-B19","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1530\/EJE-21-0729","article-title":"Long-term outcomes of patients with acromegaly: a report from the Swedish Pituitary Register","volume":"186","author":"Arnard\u00f3ttir","year":"2022","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"2026060416132333900_dgag150-B20","first-page":"448","article-title":"High prevalence of acromegaly in different industrial areas: a population-based study from Haifa and Western Galilee District in Northern Israel","volume":"24","author":"Zaina","year":"2022","journal-title":"Isr Med Assoc J"},{"issue":"23","key":"2026060416132333900_dgag150-B21","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2021.36.e159","article-title":"Descriptive epidemiology and survival analysis of acromegaly in Korea","volume":"36","author":"Yun","year":"2021","journal-title":"J Korean Med Sci"},{"issue":"3","key":"2026060416132333900_dgag150-B22","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s42000-020-00191-0","article-title":"Clinical features and therapeutic outcomes of patients with acromegaly in Saudi Arabia: a retrospective analysis","volume":"19","author":"AlMalki","year":"2020","journal-title":"Hormones"},{"issue":"4","key":"2026060416132333900_dgag150-B23","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz317","article-title":"Risk for acromegaly-related comorbidities by sex in Korean acromegaly","volume":"105","author":"Park","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"11-12","key":"2026060416132333900_dgag150-B24","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1159\/000505332","article-title":"Natural history of acromegaly: incidences, re-operations, cancers, and mortality rates in a national cohort","volume":"110","author":"Wu","year":"2020","journal-title":"Neuroendocrinology"},{"issue":"4","key":"2026060416132333900_dgag150-B25","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s40618-018-0928-7","article-title":"Use of administrative health databases to estimate incidence and prevalence of acromegaly in Piedmont Region, Italy","volume":"42","author":"Caputo","year":"2019","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"2026060416132333900_dgag150-B26","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1530\/EJE-16-1064","article-title":"Changes in the management and comorbidities of acromegaly over three decades: the French Acromegaly Registry","volume":"176","author":"Maione","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2026060416132333900_dgag150-B27","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1017\/cjn.2015.301","article-title":"Sellar masses: an epidemiological study","volume":"43","author":"Al-Dahmani","year":"2016","journal-title":"Can J Neurol Sci"},{"issue":"5","key":"2026060416132333900_dgag150-B28","doi-asserted-by":"crossref","first-page":"341","DOI":"10.5144\/0256-4947.2016.341","article-title":"The epidemiology of pituitary adenomas in a community-based hospital: a retrospective single center study in Saudi Arabia","volume":"36","author":"Aljabri","year":"2016","journal-title":"Ann Saudi Med"},{"issue":"3","key":"2026060416132333900_dgag150-B29","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1530\/EJE-16-0117","article-title":"Acromegaly incidence, prevalence, complications and long-term prognosis: a nationwide cohort study","volume":"175","author":"Dal","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2026060416132333900_dgag150-B30","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1590\/2359-3997000000195","article-title":"Incidence and prevalence of clinically relevant pituitary adenomas: retrospective cohort study in a Health Management Organization in Buenos Aires","volume":"60","author":"Fainstein Day","year":"2016","journal-title":"Arch Endocrinol Metab"},{"issue":"7","key":"2026060416132333900_dgag150-B31","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.endonu.2016.03.009","article-title":"Epidemiology of acromegaly in Ecuador","volume":"63","author":"L\u00f3pez Gavilanez","year":"2016","journal-title":"Endocrinol Nutr"},{"issue":"11","key":"2026060416132333900_dgag150-B32","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1210\/jc.2016-1937","article-title":"The Mexican Acromegaly Registry: clinical and biochemical characteristics at diagnosis and therapeutic outcomes","volume":"101","author":"Portocarrero-Ortiz","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2026060416132333900_dgag150-B33","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1530\/EJE-15-0189","article-title":"The epidemiology of pituitary adenomas in Iceland, 1955\u20132012: a nationwide population-based study","volume":"173","author":"Agustsson","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"2026060416132333900_dgag150-B34","first-page":"1106","article-title":"Clinical and economic burden of commercially insured patients with acromegaly in the United States: a retrospective analysis","volume":"21","author":"Placzek","year":"2015","journal-title":"J Manag Care Spec Pharm"},{"key":"2026060416132333900_dgag150-B35","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2147\/CLEP.S63758","article-title":"Acromegaly according to the Danish National Registry of Patients: how valid are ICD diagnoses and how do patterns of registration affect the accuracy of registry data?","volume":"6","author":"Dal","year":"2014","journal-title":"Clin Epidemiol"},{"issue":"4","key":"2026060416132333900_dgag150-B36","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1530\/EJE-14-0144","article-title":"The incidence rate of pituitary adenomas in western Sweden for the period 2001\u20132011","volume":"171","author":"Tjornstrand","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2026060416132333900_dgag150-B37","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s11102-012-0454-0","article-title":"Prevalence and incidence of pituitary adenomas: a population based study in Malta","volume":"16","author":"Gruppetta","year":"2013","journal-title":"Pituitary"},{"issue":"5","key":"2026060416132333900_dgag150-B38","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/cen.12207","article-title":"Control of growth hormone and IGF1 in patients with acromegaly in the UK: responses to medical treatment with somatostatin analogues and dopamine agonists","volume":"79","author":"Howlett","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2026060416132333900_dgag150-B39","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/cen.12020","article-title":"Nationwide survey of acromegaly in South Korea","volume":"78","author":"Kwon","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2026060416132333900_dgag150-B40","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/cen.12112","article-title":"Emerging trends in the diagnosis and treatment of acromegaly in Canada","volume":"79","author":"Vallette","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2026060416132333900_dgag150-B41","doi-asserted-by":"crossref","first-page":"E27","DOI":"10.25011\/cim.v35i1.16103","article-title":"Characterization of management and outcomes of patients with acromegaly in Vancouver over 30 years","volume":"35","author":"Almalki","year":"2012","journal-title":"Clin Invest Med"},{"issue":"2","key":"2026060416132333900_dgag150-B42","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1530\/EJE-12-0084","article-title":"Predictors of morbidity and mortality in acromegaly: an Italian survey","volume":"167","author":"Arosio","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"2026060416132333900_dgag150-B43","doi-asserted-by":"crossref","first-page":"e206","DOI":"10.1016\/j.ejim.2012.07.010","article-title":"Epidemiology, treatment trends and outcomes of acromegaly","volume":"23","author":"Mercieca","year":"2012","journal-title":"Eur J Intern Med"},{"issue":"4","key":"2026060416132333900_dgag150-B44","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1530\/EJE-10-0465","article-title":"Increased prevalence of acromegaly in a highly polluted area","volume":"163","author":"Cannav\u00f2","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2026060416132333900_dgag150-B45","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2265.2009.03667.x","article-title":"Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK)","volume":"72","author":"Fernandez","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"9","key":"2026060416132333900_dgag150-B46","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.1210\/jc.2010-0537","article-title":"Incidence of pituitary adenomas in Northern Finland in 1992\u20132007","volume":"95","author":"Raappana","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2026060416132333900_dgag150-B47","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1210\/jc.2008-0315","article-title":"Preoperative octreotide treatment in newly diagnosed acromegalic patients with macroadenomas increases cure short-term postoperative rates: a prospective, randomized trial","volume":"93","author":"Carlsen","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026060416132333900_dgag150-B48","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1530\/EJE-07-0358","article-title":"AcroBel\u2014the Belgian registry on acromegaly: a survey of the \u2018real-life\u2019 outcome in 418 acromegalic subjects","volume":"157","author":"Bex","year":"2007","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"2026060416132333900_dgag150-B49","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1210\/jc.2004-1381","article-title":"A nationwide survey of mortality in acromegaly","volume":"90","author":"Kauppinen-M\u00e4kelin","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026060416132333900_dgag150-B50","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1530\/eje.0.1510439","article-title":"Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Espanol de Acromegalia, REA)","volume":"151","author":"Mestron","year":"2004","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2026060416132333900_dgag150-B51","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/07435809909066141","article-title":"Clinical characteristics of acromegaly in Hong Kong","volume":"25","author":"Ko","year":"1999","journal-title":"Endocr Res"},{"issue":"1","key":"2026060416132333900_dgag150-B52","first-page":"55","article-title":"Ascertainment and natural history of treated acromegaly in Northern Ireland","volume":"59","author":"Ritchie","year":"1990","journal-title":"Ulster Med J"},{"issue":"4","key":"2026060416132333900_dgag150-B53","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.0954-6820.1988.tb15881.x","article-title":"Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984","volume":"223","author":"Bengtsson","year":"1988","journal-title":"Acta Med Scand"},{"issue":"1","key":"2026060416132333900_dgag150-B54","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2265.1980.tb03135.x","article-title":"Epidemiology of acromegaly in the Newcastle region","volume":"12","author":"Alexander","year":"1980","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"2026060416132333900_dgag150-B55","doi-asserted-by":"crossref","first-page":"102856","DOI":"10.1016\/j.arcmed.2023.102856","article-title":"Real world data on the epidemiology, diagnosis, and treatment of acromegaly: a registries-based approach","volume":"54","author":"Kerbel","year":"2023","journal-title":"Arch Med Res"},{"issue":"2","key":"2026060416132333900_dgag150-B56","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1530\/EJE-21-0216","article-title":"Global epidemiology of acromegaly: a systematic review and meta-analysis","volume":"185","author":"Crisafulli","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"2026060416132333900_dgag150-B57","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1530\/ERC-17-0253","article-title":"Acromegaly at diagnosis in 3173 patients from the Li\u00e9ge Acromegaly Survey (LAS) Database","volume":"24","author":"Petrossians","year":"2017","journal-title":"Endocr Relat Cancer"},{"issue":"5","key":"2026060416132333900_dgag150-B58","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1530\/ERC-15-0320","article-title":"Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients","volume":"22","author":"Rostomyan","year":"2015","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"2026060416132333900_dgag150-B59","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/j.1365-2265.2009.03547.x","article-title":"Age and sex as predictors of biochemical activity in acromegaly: analysis of 1485 patients from the German Acromegaly Register","volume":"71","author":"Petersenn","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2026060416132333900_dgag150-B60","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/cen.14392","article-title":"Sex differences in acromegaly at diagnosis: a nationwide cohort study and meta-analysis of the literature","volume":"94","author":"Dal","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"2026060416132333900_dgag150-B61","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s11102-016-0735-0","article-title":"\u201cMicromegaly\u201d: an update on the prevalence of acromegaly with apparently normal GH secretion in the modern era","volume":"19","author":"Butz","year":"2016","journal-title":"Pituitary"},{"issue":"5","key":"2026060416132333900_dgag150-B62","doi-asserted-by":"crossref","first-page":"R67","DOI":"10.1530\/EJE-19-1023","article-title":"Management of endocrine disease: does gender matter in the management of acromegaly?","volume":"182","author":"Lenders","year":"2020","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2026060416132333900_dgag150-B63","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s11102-015-0702-1","article-title":"Diagnosis and management of acromegaly: the patient's perspective","volume":"19","author":"Kreitschmann-Andermahr","year":"2016","journal-title":"Pituitary"},{"issue":"1","key":"2026060416132333900_dgag150-B64","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s12020-018-1764-4","article-title":"Signs and symptoms of acromegaly at diagnosis: the physician's and the patient's perspectives in the ACRO-POLIS study","volume":"63","author":"Caron","year":"2019","journal-title":"Endocrine"},{"issue":"11","key":"2026060416132333900_dgag150-B65","doi-asserted-by":"crossref","first-page":"5240","DOI":"10.1210\/jcem.86.11.8006","article-title":"The relationship between serum GH and serum IGF-I in acromegaly is gender-specific","volume":"86","author":"Parkinson","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2026060416132333900_dgag150-B66","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s11883-016-0574-5","article-title":"An update on gender disparities in coronary heart disease care","volume":"18","author":"Shah","year":"2016","journal-title":"Curr Atheroscler Rep"},{"key":"2026060416132333900_dgag150-B67","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2147\/DMSO.S51301","article-title":"Sex differences in type 2 diabetes: focus on disease course and outcomes","volume":"7","author":"Arnetz","year":"2014","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"11","key":"2026060416132333900_dgag150-B68","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1007\/s11606-013-2441-1","article-title":"Physicians and implicit bias: how doctors may unwittingly perpetuate health care disparities","volume":"28","author":"Chapman","year":"2013","journal-title":"J Gen Intern Med"},{"issue":"153","key":"2026060416132333900_dgag150-B69","first-page":"1","article-title":"Mortality in acromegaly","volume":"39","author":"Wright","year":"1970","journal-title":"Q J Med"},{"issue":"1","key":"2026060416132333900_dgag150-B70","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1210\/jc.2007-1191","article-title":"Mortality in acromegaly: a metaanalysis","volume":"93","author":"Dekkers","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026060416132333900_dgag150-B71","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1210\/er.2009-0033","article-title":"Mortality in patients with pituitary disease","volume":"31","author":"Sherlock","year":"2010","journal-title":"Endocr Rev"},{"issue":"2","key":"2026060416132333900_dgag150-B72","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1530\/EJE-08-0267","article-title":"A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly","volume":"159","author":"Holdaway","year":"2008","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2026060416132333900_dgag150-B73","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1530\/EJE-18-0015","article-title":"Decreasing mortality and changes in treatment patterns in patients with acromegaly from a nationwide study","volume":"178","author":"Esposito","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2026060416132333900_dgag150-B74","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1530\/ERC-16-0106","article-title":"Mortality in acromegaly: a 20-year follow-up study","volume":"23","author":"Ritvonen","year":"2016","journal-title":"Endocr Relat Cancer"},{"issue":"12","key":"2026060416132333900_dgag150-B75","doi-asserted-by":"crossref","first-page":"4438","DOI":"10.1210\/jc.2014-2670","article-title":"Successful mortality reduction and control of comorbidities in patients with acromegaly followed at a highly specialized multidisciplinary clinic","volume":"99","author":"Mercado","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2026060416132333900_dgag150-B76","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1530\/ERC-16-0553","article-title":"Acromegaly is associated with increased cancer risk: a survey in Italy","volume":"24","author":"Terzolo","year":"2017","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"2026060416132333900_dgag150-B77","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1365-2265.2009.03619.x","article-title":"Increased cancer incidence in acromegaly\u2013a nationwide survey","volume":"72","author":"Kauppinen-M\u00e4kelin","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2026060416132333900_dgag150-B78","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1365-2265.1998.00536.x","article-title":"Increased incidence of neoplasia in patients with pituitary adenomas. The Pituitary Study Group.","volume":"49","author":"Popovic","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"2026060416132333900_dgag150-B79","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1002\/1097-0142(19911015)68:8<1673::AID-CNCR2820680802>3.0.CO;2-0","article-title":"Acromegaly and gastrointestinal cancer","volume":"68","author":"Ron","year":"1991","journal-title":"Cancer"},{"issue":"8","key":"2026060416132333900_dgag150-B80","first-page":"2730","article-title":"Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group","volume":"83","author":"Orme","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2026060416132333900_dgag150-B81","doi-asserted-by":"crossref","first-page":"3894","DOI":"10.1210\/jc.2015-2372","article-title":"The incidence of cancer among acromegaly patients: results from the German acromegaly registry","volume":"100","author":"Petroff","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2026060416132333900_dgag150-B82","first-page":"3487","article-title":"Incidence of benign and malignant tumors in patients with acromegaly is increased: a nationwide population-based study","volume":"106","author":"Esposito","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026060416132333900_dgag150-B83","doi-asserted-by":"crossref","first-page":"R147","DOI":"10.1530\/EJE-16-0178","article-title":"Management of endocrine disease: acromegaly and cancer: an old debate revisited","volume":"175","author":"Boguszewski","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2026060416132333900_dgag150-B84","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1210\/jc.2003-031199","article-title":"Factors influencing mortality in acromegaly","volume":"89","author":"Holdaway","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026060416132333900_dgag150-B85","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s11154-020-09588-z","article-title":"Multidisciplinary management of acromegaly: a consensus","volume":"21","author":"Giustina","year":"2020","journal-title":"Rev Endocr Metab Disord"},{"issue":"2","key":"2026060416132333900_dgag150-B86","doi-asserted-by":"crossref","first-page":"101264","DOI":"10.1016\/j.beem.2019.02.001","article-title":"National acromegaly registries","volume":"33","author":"Maione","year":"2019","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"3","key":"2026060416132333900_dgag150-B87","doi-asserted-by":"crossref","first-page":"e532","DOI":"10.1210\/clinem\/dgz187","article-title":"Biochemical control in acromegaly with multimodality therapies: outcomes from a pituitary center and changes over time","volume":"105","author":"Ghajar","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2026060416132333900_dgag150-B88","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/s41574-025-01148-2","article-title":"Consensus on acromegaly therapeutic outcomes: an update","volume":"21","author":"Melmed","year":"2025","journal-title":"Nat Rev Endocrinol"},{"key":"2026060416132333900_dgag150-B89","doi-asserted-by":"crossref","first-page":"1380436","DOI":"10.3389\/fendo.2024.1380436","article-title":"Changes in acromegaly comorbidities, treatment, and outcome over three decades: a nationwide cohort study","volume":"15","author":"Rosendal","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"2026060416132333900_dgag150-B90","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/s41574-018-0058-5","article-title":"A consensus statement on acromegaly therapeutic outcomes","volume":"14","author":"Melmed","year":"2018","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"2026060416132333900_dgag150-B91","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1210\/jc.2003-031584","article-title":"Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly","volume":"89","author":"Ayuk","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"21","key":"2026060416132333900_dgag150-B92","first-page":"1106","article-title":"Acromegaly: a review of 100 cases","volume":"87","author":"Gordon","year":"1962","journal-title":"Can Med Assoc J"},{"issue":"4","key":"2026060416132333900_dgag150-B93","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-2265.1987.tb00805.x","article-title":"Acromegaly","volume":"26","author":"Nabarro","year":"1987","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2026060416132333900_dgag150-B94","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1530\/EJE-12-0602","article-title":"Long-term outcome in patients with acromegaly: analysis of 1344 patients from the German Acromegaly Register","volume":"168","author":"Sch\u00f6fl","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"2026060416132333900_dgag150-B95","doi-asserted-by":"crossref","first-page":"4216","DOI":"10.1210\/jc.2009-1097","article-title":"ACTH deficiency, higher doses of hydrocortisone replacement, and radiotherapy are independent predictors of mortality in patients with acromegaly","volume":"94","author":"Sherlock","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026060416132333900_dgag150-B96","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.tem.2014.10.005","article-title":"Growth hormone deficiency in treated acromegaly","volume":"26","author":"Mazziotti","year":"2015","journal-title":"Trends Endocrinol Metab"},{"issue":"6","key":"2026060416132333900_dgag150-B97","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1210\/endrev\/bnac010","article-title":"Clinical biology of the pituitary adenoma","volume":"43","author":"Melmed","year":"2022","journal-title":"Endocr Rev"},{"key":"2026060416132333900_dgag150-B98","doi-asserted-by":"crossref","first-page":"577173","DOI":"10.3389\/fendo.2020.577173","article-title":"Hypertension in acromegaly in relationship to biochemical control and mortality: global ACROSTUDY outcomes","volume":"11","author":"Vila","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"2026060416132333900_dgag150-B99","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41574-024-00993-x","article-title":"Diabetes mellitus in patients with acromegaly: pathophysiology, clinical challenges and management","volume":"20","author":"Esposito","year":"2024","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"2026060416132333900_dgag150-B100","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11102-013-0471-7","article-title":"Prevalence and risk factors of impaired glucose tolerance and diabetes mellitus at diagnosis of acromegaly: a study in 148 patients","volume":"17","author":"Alexopoulou","year":"2014","journal-title":"Pituitary"},{"issue":"4","key":"2026060416132333900_dgag150-B101","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s11102-023-01322-7","article-title":"Prevalence of clinical signs, symptoms and comorbidities at diagnosis of acromegaly: a systematic review in accordance with PRISMA guidelines","volume":"26","author":"Slagboom","year":"2023","journal-title":"Pituitary"},{"issue":"6","key":"2026060416132333900_dgag150-B102","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1210\/jc.2018-00325","article-title":"Persistence of diabetes and hypertension after multimodal treatment of acromegaly","volume":"103","author":"Gonz\u00e1lez","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2026060416132333900_dgag150-B103","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1210\/clinem\/dgac400","article-title":"Effect of diabetes on morbidity and mortality in patients with acromegaly","volume":"107","author":"Esposito","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026060416132333900_dgag150-B104","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s11102-025-01629-7","article-title":"Gender differences in the glycometabolic and cardiovascular features of acromegaly","volume":"29","author":"Gatto","year":"2026","journal-title":"Pituitary"},{"issue":"9","key":"2026060416132333900_dgag150-B105","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1210\/clinem\/dgaa405","article-title":"Disease control and gender predict the socioeconomic effects of acromegaly: a nationwide cohort study","volume":"105","author":"Dal","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2026060416132333900_dgag150-B106","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/ejendo\/lvad106","article-title":"Sex differences in mortality in patients with acromegaly: a nationwide cohort study in Korea","volume":"189","author":"Kim","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"2026060416132333900_dgag150-B107","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1210\/clinem\/dgad141","article-title":"Mortality in acromegaly diagnosed in older individuals in Spain is higher in women compared to the general Spanish population","volume":"108","author":"Biagetti","year":"2023","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgag150\/67989169\/dgag150.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/Supplement_1\/S1\/67989169\/dgag150.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/Supplement_1\/S1\/67989169\/dgag150.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T20:13:39Z","timestamp":1780604019000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/111\/Supplement_1\/S1\/8643915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,8]]},"references-count":107,"journal-issue":{"issue":"Supplement_1","published-online":{"date-parts":[[2026,4,8]]},"published-print":{"date-parts":[[2026,6,4]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgag150","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2026,4,8]]}}}